Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
15,271,786
-
Share change
-
+286,014
-
Total reported value
-
$185,247,550
-
Price per share
-
$12.13
-
Number of holders
-
25
-
Value change
-
+$2,630,228
-
Number of buys
-
14
-
Number of sells
-
8
Institutional Holders of AMRYT PHARMA PLC - SPONSORED ADS (AMYT) as of Q2 2021
As of 30 Jun 2021,
AMRYT PHARMA PLC - SPONSORED ADS (AMYT) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,271,786 shares.
The largest 10 holders included
Athyrium Capital Management, LP, Stonepine Capital Management, LLC, EdgePoint Investment Group Inc., UBS OCONNOR LLC, Aquilo Capital Management, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, SILVERARC CAPITAL MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, Global Frontier Investments LLC, and AMERIPRISE FINANCIAL INC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.